Antibiotic stewardship interventions for acute respiratory infection (ARI) is feasible and effective and can significantly reduce overuse in the emergency department (ED) and urgent care center (UCC) settings. That is the conclusion of a study to be published in Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM).
The multicenter interventional study - the first to evaluate the effectiveness of the Core Elements of Outpatient Antibiotic Stewardship when implemented as a bundle - compared two approaches designed to help physicians make better antibiotic-prescribing decisions for viral acute respiratory infections (ARIs) without limiting the choices available.
The overuse of antibiotics in hospitals, physicians' offices and large-scale livestock farming causes the rise of antibiotic resistances.
Products and exhibitors around infection care
Exhibitors and products related to these topics can be found in the catalogue of MEDICA 2019:
The lead author of the study is Kabir Yadav, MD, Department of Emergency Medicine, Harbor UCLA Medical Center, Torrance.
Yadav, et al. found that while overall performance improvements are still needed in systems with both high and low performers, the study demonstrates that getting to zero inappropriate antibiotic use for ARIs is a potentially achievable goal, and for those institutions with average or high inappropriate prescribing rates, antibiotic overuse can be cut by one third, with attention to the problem.
Commenting on the study is David A. Talan, MD, professor of medicine in residence (emeritus), David Geffen School of Medicine at UCLA: "While this study did not demonstrate a significant reduction in inappropriate antibiotic use for upper respiratory tract infections with an enhanced educational campaign supplemented by peer comparison, the good news is that its rates are already remarkably low (~5%) in some emergency departments (EDs), and these campaigns appear feasible for EDs seeking more comprehensive models to improve stewardship and for application to other targets, such as urinary tract infections and shotgun empirical broad-spectrum IV treatments (e.g., vancomycin and piperaciilin/tazobactam)."
MEDICA-tradefair.com; Source: Society for Academic Emergency Medicine